Back
CRISPR Therapeutics AG Vs. Intellia Therapeutics Industry Stock Comparison
Sell
45
CRSP
CRISPR Therapeutics AG
Last Price:
52.35
Seasonality Move:
27.39%
Sell
37
NTLA
Intellia Therapeutics
Last Price:
24.53
Seasonality Move:
37.64%
Sell
45
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $53.29. The Score for CRSP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $23.00. The Score for NTLA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $53.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing slight selling pressure.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $23.00
The current trend is relatively stagnant and NTLA is experiencing slight selling pressure.
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3 | Sell |
| Relative Strength Index (14 RSI): | 34.38 | Sell |
| Chaikin Money Flow: | -437080 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.77 - 61.43) | Sell |
| Bollinger Bands (100): | (57.92 - 76.08) | Sell |
NTLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.56 | Sell |
| Relative Strength Index (14 RSI): | 47.14 | Sell |
| Chaikin Money Flow: | -615055 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.3 - 24.56) | Buy |
| Bollinger Bands (100): | (23.73 - 30.01) | Sell |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.82 | Sell |
| 20-day SMA: | 56.05 | Sell |
| 50-day SMA: | 66.2 | Sell |
| 200-day SMA: | 59.36 | Sell |
| 8-day EMA: | 55.02 | Sell |
| 20-day EMA: | 57.12 | Sell |
| 50-day EMA: | 62.35 | Sell |
| 200-day EMA: | 61.92 | Sell |
NTLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.92 | Buy |
| 20-day SMA: | 22.36 | Buy |
| 50-day SMA: | 25.75 | Sell |
| 200-day SMA: | 29.78 | Sell |
| 8-day EMA: | 22.97 | Buy |
| 20-day EMA: | 23.07 | Sell |
| 50-day EMA: | 24.66 | Sell |
| 200-day EMA: | 30.04 | Sell |
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.54 per share, a decrease next quarter of $0.17 per share, a decrease this year of $2.67 per share, and an increase next year of $1.62 per share.
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.13 per share, and an increase next year of $0.01 per share.
CRISPR Therapeutics AG Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Intellia Therapeutics Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||